These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 180807)

  • 21. Ovarian hyperthecosis in the adolescent patient.
    Wentz AC; Gutai JP; Jones GS; Migeon CJ
    J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polycystic ovary syndrome (author's transl)].
    Lecomte P; Kuttenn F; Mauvais-Jarvis P
    Nouv Presse Med; 1978 Feb; 7(5):355-6, 361-2. PubMed ID: 345233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of Hypothalamic-Pituitary-Adrenal Axis and Hypothalamus-Pituitary-Ovary Axis in the Abnormal Endocrine Functions in Patients with Polycystic Ovary Syndrome.
    Wang F; Zhang ZH; Xiao KZ; Wang ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):699-704. PubMed ID: 29125115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of polycystic ovary syndrome.
    Mauvais-Jarvis P; Bricaire C
    J Steroid Biochem; 1989 Oct; 33(4B):791-4. PubMed ID: 2513454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease.
    Yen SS; Vela P; Rankin J
    J Clin Endocrinol Metab; 1970 Apr; 30(4):435-42. PubMed ID: 5435284
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical use of hormone assays in the management of female infertility.
    Blasco L; Mikhail G
    Clin Obstet Gynecol; 1974 Dec; 17(4):79-85. PubMed ID: 4615865
    [No Abstract]   [Full Text] [Related]  

  • 29. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polycystic ovary syndrome of extra-ovarian origin. Review].
    Terán Dávila J; Teppa-Garrán AD
    Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of androgen excess on inappropriate gonadotropin secretion as found in the polycystic ovary syndrome.
    Lobo RA; Goebelsmann U
    Am J Obstet Gynecol; 1982 Feb; 142(4):394-401. PubMed ID: 6460446
    [No Abstract]   [Full Text] [Related]  

  • 32. Some new thoughts on the Stein-Leventhal syndrome.
    Greenblatt RB; Mahesh VB
    J Reprod Med; 1974 Sep; 13(3):85-8. PubMed ID: 4415831
    [No Abstract]   [Full Text] [Related]  

  • 33. Adrenal and gonadal contribution to circulating androgens in spotted hyaenas (Crocuta crocuta) as revealed by LHRH, hCG and ACTH stimulation.
    Lindeque M; Skinner JD; Millar RP
    J Reprod Fertil; 1986 Sep; 78(1):211-7. PubMed ID: 3020243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
    Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results suggesting exaggerated ovarian androgen production early in the course of polycystic ovary syndrome.
    Francis GL; Getts A; McPherson JC
    J Adolesc Health Care; 1990 Nov; 11(6):480-4. PubMed ID: 2262393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW; McEvoy D; Wallach EE
    Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
    [No Abstract]   [Full Text] [Related]  

  • 38. Adrenal abnormalities in polycystic ovary syndrome.
    Loughlin T; Cunningham S; Moore A; Culliton M; Smyth PP; McKenna TJ
    J Clin Endocrinol Metab; 1986 Jan; 62(1):142-7. PubMed ID: 3079598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Variability of the adrenal involvement in the polycystic ovary syndrome].
    Boccuzzi G
    Minerva Endocrinol; 1987; 12(3):213-6. PubMed ID: 2821374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.